Production and characterization of polyclonal anti-S 20499 antibodies: Influence of the hapten structure on stereospecificity

Journal of Pharmaceutical Sciences

Volumn 86, Issue 6, 1997, Pages 654-659

  Got, Pierre A ^a   Guillaumet, Gerald ^b   Boursier Neyret, Claire ^a   Scherrmann, Jean Michel ^c  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALNESPIRONE; ANXIOLYTIC AGENT; BUSPIRONE; DRUG ANTIBODY; HAPTEN; POLYCLONAL ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; ENANTIOMER; IMMUNOASSAY; NONHUMAN; RABBIT; STEREOSPECIFICITY;

EID: 0030989237     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9700107     Document Type: Article

References (27)

1. Kupfer, A.; Roberts, R. K.; Schenker, S.; Branch, R. A. J. Pharmacol. Exp. Ther. 1981, 218, 193-199.
2. Campbell, D. B. Eur. J. Drug Metab. Pharmacokinet. 1990, 15(2), 109-125.
3. Drayer, D. E. Clin. Pharmacol. Ther. 1986, 40, 125-132.
4. Lee, E. J. D.; Williams, K. M. Clin. Pharmacokinet. 1990, 18(5), 339-345.
5. Gal, J. In Drug Stereochemistry; Wainer, J. W., Ed.; M. Dekker: New York, 1993; pp 65-106.
6. Srinivas, N. R.; Igwemezie, L. N. Biomed. Chromatogr. 1992, 6, 163-167.
7. Mehta, A. C. J. Chromatogr. 1988, 426, 1-13.
8. Wainer, I. W. In Drug Stereochemistry; Wainer, J. W., Ed.; M. Dekker: New York, 1993; pp 139-182.
9. Sahui-Gnassi, A.; Pham-Huy, C.; Galons, H.; Warnet, J. M.; Claude, J. R.; Duc, H. T. Chirality 1993, 5, 448-454.
10. Sidki, A. M.; Al-Abdulla, H.; Rowell, F. J. Clin. Chem. 1987, 33(4), 463-467.
11. Rominger, K. L.; Mentrup, A.; Stiasni, M. Drug Res. 1990, 40-II(8), 887-895.
12. Niwaguchi, T.; Kanda, Y.; Kishi, T.; Inoue, T. J. Forensic Sci. 1982, 27(3), 592-597.
13. Chappey, O.; Sandouk, P.; Scherrmann, J. M. S. J. Clin. Immunoassay 1992, 15(1), 51-56.
14. Podona, T.; Guardiola-Lemaitre, B.; Caignard, D. H.; Adam, G.; Pfeiffer, B.; Renard, P.; Guillaumet, G. J. Med. Chem. 1994, 37(12), 1779-1793.
15. Bodansky, A. In The Practice of Peptide Synthesis-Reactivity and Structure Concepts in Organic Chemistry, vol. 21; Hafner, K.; Lehn, J. M.; Rees, C. W.; von Ragué Schleyer, P.; Trost, B. M.; Zahradnik, R., Eds.; Springer-Verlag: Berlin, Heidelberg, New York, Tokyo, 1984; pp 109-110.
16. Abraham, G. E. J. Clin. Endocrinol. 1969, 29, 866-870.
17. Müller, R. J. Immunol. Meth. 1980, 34, 345-352.
18. Jajoo, H. K.; Mayol, R. F.; Labudde, J. A.; Blair, I. A. Drug Metab. Dispos. 1989, 17(6), 625-633.
19. Cipollina, J. A.; Ruediger, E. H.; New, J. S.; Wire, M. E.; Shepherd, T. A.; Smith, D. W.; Yevich, J. P. J. Med. Chem. 1991, 34, 3316-3328.
20. Landsteiner, K. In The Specificity of Serological Reactions; Harvard University: Boston, 1945 (reprinted by Dover, New York, 1962).
21. McGilliard, P. L.; Olsen, G. D. J. Pharm. Exp. Ther. 1980, 215(1), 205-212.
22. Findlay, J. W. A.; Warren, J. T.; Hill, J. A.; Welch, R. M. J. Pharm. Sci. 1981l 70(6), 624-631.
23. Morel, A.; Darmon, M.; Delaage, M. Mol. Immunol. 1990, 27(10), 995-1000.
24. Cook, C. E. In Drug Stereochemistry; Wainer, J. W., Ed.; M. Dekker: New York, 1993; pp 35-64.
25. Sawutz, D. G.; Sylvestre, D.; Homey, C. J. J. Immunol. 1985, 135(4), 2713-2718.
26. Chatenoud, L.; Villemain, F.; Hoebeke, J.; Garbarg, M.; Korner, M.; Gros, C.; Ruat, M.; Cazenave, P. A.; Ganellin, C. R.; Bach, J. F.; Schwartz, J. C. Mol. Pharmacol. 1988, 34, 136-144.
27. Cook, E. C.; Seltzman, T. B.; Tallent, C. R.; Lorenzo, B.; Drayer, D. E. J. Pharmacol. Exp. Ther. 1987, 241(3), 779-785.